 | • レポートコード：GIR-105X01082 • 出版社/出版日：GlobalInfoResearch / 2021年5月 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、103ページ • 納品方法：Eメール（納期：2~3日） • 産業分類：Pharma & Healthcare |
| Single User | ￥515,040 (USD3,480) | ▷ お問い合わせ |
| Multi User | ￥772,560 (USD5,220) | ▷ お問い合わせ |
| Corporate User | ￥1,030,080 (USD6,960) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 当調査資料では、抗高血圧薬のグローバル市場について調査・分析し、2021年から2026年までの市場予測をまとめております。抗高血圧薬の種類別市場規模（利尿薬、アンジオテンシン変換酵素（ACE）阻害薬、アンジオテンシン受容体遮断薬（ARB）、カルシウムチャネル遮断薬、ベータ遮断薬、アルファ遮断薬、血管拡張薬、レニン阻害薬）、用途別市場規模（病院薬局、小売薬局、オンライン薬局）、地域別市場規模（北米、アメリカ、ヨーロッパ、アジア、中国、日本、東南アジア、南米、中東、アフリカなど）、市場動向、企業別販売量と市場シェア、販売チャネルなどの情報を掲載しています。 ・抗高血圧薬の市場概要 ・企業情報（企業概要、製品概要、販売量、価格、売上）：Novartis、Pfizer、Johnson & Johnson、Sanofi、Lupin、Ranbaxy Laboratories、Merck、AstraZeneca、Daiichi Sankyo Company Limited、Takeda Pharmaceutical ・企業別市場シェア ・地域別市場分析2016年-2026年 ・種類別分析2016年-2026年：利尿薬、アンジオテンシン変換酵素（ACE）阻害薬、アンジオテンシン受容体遮断薬（ARB）、カルシウムチャネル遮断薬、ベータ遮断薬、アルファ遮断薬、血管拡張薬、レニン阻害薬 ・用途別分析2016年-2026年：病院薬局、小売薬局、オンライン薬局 ・抗高血圧薬の北米市場規模2016年-2026年：アメリカ、カナダ、メキシコ ・抗高血圧薬のヨーロッパ市場規模2016年-2026年：ドイツ、イギリス、フランス、ロシア、イタリア ・抗高血圧薬のアジア市場規模2016年-2026年：中国、日本、韓国、インド、東南アジア、オーストラリア ・抗高血圧薬の南米市場規模2016年-2026年：ブラジル、アルゼンチン ・抗高血圧薬の中東・アフリカ市場規模2016年-2026年：サウジアラビア、トルコ、エジプト、南アフリカ ・販売チャネル、流通業者・代理店、顧客リスト ・調査の結果・結論 |
The Anti-Hypertensive Drugs market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.
According to our latest research, the global Anti-Hypertensive Drugs size is estimated to be xx million in 2020 from USD 41430 million in 2019, with a change of XX% between 2019 and 2020. The global Anti-Hypertensive Drugs market size is expected to grow at a CAGR of 1.6% for the next five years.
Market segmentation
Anti-Hypertensive Drugs market is split by Type and by Application. For the period 2016-2026, the growth among segments provide accurate calculations and forecasts for sales by Type and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type, covers
Diuretics
Angiotensin Converting Enzyme (ACE) Inhibitors
Angiotensin Receptor Blockers (ARBs)
Calcium Channel Blockers
Beta Blockers
Alpha Blockers
Vasodilators
Renin Inhibitors
Market segment by Application can be divided into
Hospital Pharmacies
Retail Pharmacies
Online Pharmacies
The key market players for global Anti-Hypertensive Drugs market are listed below:
Novartis
Pfizer
Johnson & Johnson
Sanofi
Lupin
Ranbaxy Laboratories
Merck
AstraZeneca
Daiichi Sankyo Company Limited
Takeda Pharmaceutical
Market segment by Region, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
South America (Brazil, Argentina, Colombia, and Rest of South America)
Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
1 Market Overview
1.1 Anti-Hypertensive Drugs Introduction
1.2 Market Analysis by Type
1.2.1 Overview: Global Anti-Hypertensive Drugs Revenue by Type: 2019 Versus 2021 Versus 2026
1.2.2 Diuretics
1.2.3 Angiotensin Converting Enzyme (ACE) Inhibitors
1.2.4 Angiotensin Receptor Blockers (ARBs)
1.2.5 Calcium Channel Blockers
1.2.6 Beta Blockers
1.2.7 Alpha Blockers
1.2.8 Vasodilators
1.2.9 Renin Inhibitors
1.3 Market Analysis by Application
1.3.1 Overview: Global Anti-Hypertensive Drugs Revenue by Application: 2019 Versus 2021 Versus 2026
1.3.2 Hospital Pharmacies
1.3.3 Retail Pharmacies
1.3.4 Online Pharmacies
1.4 Global Anti-Hypertensive Drugs Market Size & Forecast
1.4.1 Global Anti-Hypertensive Drugs Sales in Value (2016-2026))
1.4.2 Global Anti-Hypertensive Drugs Sales in Volume (2016-2026)
1.4.3 Global Anti-Hypertensive Drugs Price by Type (2016-2026) & (USD/Pcs)
1.5 Global Anti-Hypertensive Drugs Production Capacity Analysis
1.5.1 Global Anti-Hypertensive Drugs Total Production Capacity (2016-2026)
1.5.2 Global Anti-Hypertensive Drugs Production Capacity by Geographic Region
1.6 Market Drivers, Restraints and Trends
1.6.1 Anti-Hypertensive Drugs Market Drivers
1.6.2 Anti-Hypertensive Drugs Market Restraints
1.6.3 Anti-Hypertensive Drugs Trends Analysis
2 Manufacturers Profiles
2.1 Novartis
2.1.1 Novartis Details
2.1.2 Novartis Major Business
2.1.3 Novartis Anti-Hypertensive Drugs Product and Services
2.1.4 Novartis Anti-Hypertensive Drugs Sales, Price, Revenue, Gross Margin and Market Share (2019-2021e)
2.2 Pfizer
2.2.1 Pfizer Details
2.2.2 Pfizer Major Business
2.2.3 Pfizer Anti-Hypertensive Drugs Product and Services
2.2.4 Pfizer Anti-Hypertensive Drugs Sales, Price, Revenue, Gross Margin and Market Share (2019-2021e)
2.3 Johnson & Johnson
2.3.1 Johnson & Johnson Details
2.3.2 Johnson & Johnson Major Business
2.3.3 Johnson & Johnson Anti-Hypertensive Drugs Product and Services
2.3.4 Johnson & Johnson Anti-Hypertensive Drugs Sales, Price, Revenue, Gross Margin and Market Share (2019-2021e)
2.4 Sanofi
2.4.1 Sanofi Details
2.4.2 Sanofi Major Business
2.4.3 Sanofi Anti-Hypertensive Drugs Product and Services
2.4.4 Sanofi Anti-Hypertensive Drugs Sales, Price, Revenue, Gross Margin and Market Share (2019-2021e)
2.5 Lupin
2.5.1 Lupin Details
2.5.2 Lupin Major Business
2.5.3 Lupin Anti-Hypertensive Drugs Product and Services
2.5.4 Lupin Anti-Hypertensive Drugs Sales, Price, Revenue, Gross Margin and Market Share (2019-2021e)
2.6 Ranbaxy Laboratories
2.6.1 Ranbaxy Laboratories Details
2.6.2 Ranbaxy Laboratories Major Business
2.6.3 Ranbaxy Laboratories Anti-Hypertensive Drugs Product and Services
2.6.4 Ranbaxy Laboratories Anti-Hypertensive Drugs Sales, Price, Revenue, Gross Margin and Market Share (2019-2021e)
2.7 Merck
2.7.1 Merck Details
2.7.2 Merck Major Business
2.7.3 Merck Anti-Hypertensive Drugs Product and Services
2.7.4 Merck Anti-Hypertensive Drugs Sales, Price, Revenue, Gross Margin and Market Share (2019-2021e)
2.8 AstraZeneca
2.8.1 AstraZeneca Details
2.8.2 AstraZeneca Major Business
2.8.3 AstraZeneca Anti-Hypertensive Drugs Product and Services
2.8.4 AstraZeneca Anti-Hypertensive Drugs Sales, Price, Revenue, Gross Margin and Market Share (2019-2021e)
2.9 Daiichi Sankyo Company Limited
2.9.1 Daiichi Sankyo Company Limited Details
2.9.2 Daiichi Sankyo Company Limited Major Business
2.9.3 Daiichi Sankyo Company Limited Anti-Hypertensive Drugs Product and Services
2.9.4 Daiichi Sankyo Company Limited Anti-Hypertensive Drugs Sales, Price, Revenue, Gross Margin and Market Share (2019-2021e)
2.10 Takeda Pharmaceutical
2.10.1 Takeda Pharmaceutical Details
2.10.2 Takeda Pharmaceutical Major Business
2.10.3 Takeda Pharmaceutical Anti-Hypertensive Drugs Product and Services
2.10.4 Takeda Pharmaceutical Anti-Hypertensive Drugs Sales, Price, Revenue, Gross Margin and Market Share (2019-2021e)
3 Anti-Hypertensive Drugs Sales by Manufacturer
3.1 Global Anti-Hypertensive Drugs Sales in Volume by Manufacturer (2019-2021e)
3.2 Global Anti-Hypertensive Drugs Revenue by Manufacturer (2019-2021e)
3.3 Key Manufacturer Market Position in Anti-Hypertensive Drugs
3.4 Market Concentration Rate
3.4.1 Top 3 Anti-Hypertensive Drugs Manufacturer Market Share
3.4.2 Top 6 Anti-Hypertensive Drugs Manufacturer Market Share
3.5 Global Anti-Hypertensive Drugs Production Capacity by Company
3.6 Manufacturer by Geography: Head Office and Anti-Hypertensive Drugs Production Site
3.7 New Entrant and Capacity Expansion Plans
3.8 Mergers & Acquisitions
4 Market Analysis by Region
4.1 Global Anti-Hypertensive Drugs Market Size by Region
4.1.1 Global Anti-Hypertensive Drugs Sales in Volume by Region (2016-2026)
4.1.2 Global Anti-Hypertensive Drugs Revenue by Region (2016-2026)
4.2 North America Anti-Hypertensive Drugs Revenue (2016-2026)
4.3 Europe Anti-Hypertensive Drugs Revenue (2016-2026)
4.4 Asia-Pacific Anti-Hypertensive Drugs Revenue (2016-2026)
4.5 South America Anti-Hypertensive Drugs Revenue (2016-2026)
4.6 Middle East and Africa Anti-Hypertensive Drugs Revenue (2016-2026)
5 Market Segment by Type
5.1 Global Anti-Hypertensive Drugs Sales in Volume by Type (2016-2026)
5.2 Global Anti-Hypertensive Drugs Revenue by Type (2016-2026)
5.3 Global Anti-Hypertensive Drugs Price by Type (2016-2026)
6 Market Segment by Application
6.1 Global Anti-Hypertensive Drugs Sales in Volume by Application (2016-2026)
6.2 Global Anti-Hypertensive Drugs Revenue by Application (2016-2026)
6.3 Global Anti-Hypertensive Drugs Price by Application (2016-2026)
7 North America by Country, by Type, and by Application
7.1 North America Anti-Hypertensive Drugs Sales by Type (2016-2026)
7.2 North America Anti-Hypertensive Drugs Sales by Application (2016-2026)
7.3 North America Anti-Hypertensive Drugs Market Size by Country
7.3.1 North America Anti-Hypertensive Drugs Sales in Volume by Country (2016-2026)
7.3.2 North America Anti-Hypertensive Drugs Revenue by Country (2016-2026)
7.3.3 United States Market Size and Forecast (2016-2026)
7.3.4 Canada Market Size and Forecast (2016-2026)
7.3.5 Mexico Market Size and Forecast (2016-2026)
8 Europe by Country, by Type, and by Application
8.1 Europe Anti-Hypertensive Drugs Sales by Type (2016-2026)
8.2 Europe Anti-Hypertensive Drugs Sales by Application (2016-2026)
8.3 Europe Anti-Hypertensive Drugs Market Size by Country
8.3.1 Europe Anti-Hypertensive Drugs Sales in Volume by Country (2016-2026)
8.3.2 Europe Anti-Hypertensive Drugs Revenue by Country (2016-2026)
8.3.3 Germany Market Size and Forecast (2016-2026)
8.3.4 France Market Size and Forecast (2016-2026)
8.3.5 United Kingdom Market Size and Forecast (2016-2026)
8.3.6 Russia Market Size and Forecast (2016-2026)
8.3.7 Italy Market Size and Forecast (2016-2026)
9 Asia-Pacific by Country, by Type, and by Application
9.1 Asia-Pacific Anti-Hypertensive Drugs Sales by Type (2016-2026)
9.2 Asia-Pacific Anti-Hypertensive Drugs Sales by Application (2016-2026)
9.3 Asia-Pacific Anti-Hypertensive Drugs Market Size by Region
9.3.1 Asia-Pacific Anti-Hypertensive Drugs Sales in Volume by Region (2016-2026)
9.3.2 Asia-Pacific Anti-Hypertensive Drugs Revenue by Region (2016-2026)
9.3.3 China Market Size and Forecast (2016-2026)
9.3.4 Japan Market Size and Forecast (2016-2026)
9.3.5 Korea Market Size and Forecast (2016-2026)
9.3.6 India Market Size and Forecast (2016-2026)
9.3.7 Southeast Asia Market Size and Forecast (2016-2026)
9.3.8 Australia Market Size and Forecast (2016-2026)
10 South America by Country, by Type, and by Application
10.1 South America Anti-Hypertensive Drugs Sales by Type (2016-2026)
10.2 South America Anti-Hypertensive Drugs Sales by Application (2016-2026)
10.3 South America Anti-Hypertensive Drugs Market Size by Country
10.3.1 South America Anti-Hypertensive Drugs Sales in Volume by Country (2016-2026)
10.3.2 South America Anti-Hypertensive Drugs Revenue by Country (2016-2026)
10.3.3 Brazil Market Size and Forecast (2016-2026)
10.3.4 Argentina Market Size and Forecast (2016-2026)
11 Middle East & Africa by Country, by Type, and by Application
11.1 Middle East & Africa Anti-Hypertensive Drugs Sales by Type (2016-2026)
11.2 Middle East & Africa Anti-Hypertensive Drugs Sales by Application (2016-2026)
11.3 Middle East & Africa Anti-Hypertensive Drugs Market Size by Country
11.3.1 Middle East & Africa Anti-Hypertensive Drugs Sales in Volume by Country (2016-2026)
11.3.2 Middle East & Africa Anti-Hypertensive Drugs Revenue by Country (2016-2026)
11.3.3 Turkey Market Size and Forecast (2016-2026)
11.3.4 Egypt Market Size and Forecast (2016-2026)
11.3.5 Saudi Arabia Market Size and Forecast (2016-2026)
11.3.6 South Africa Market Size and Forecast (2016-2026)
12 Sales Channel, Distributors, Traders and Dealers
12.1 Sales Channel
12.1.1 Direct Marketing
12.1.2 Indirect Marketing
12.2 Anti-Hypertensive Drugs Typical Distributors
12.3 Anti-Hypertensive Drugs Typical Customers
13 Research Findings and Conclusion
14 Appendix
14.1 Methodology
14.2 Research Process and Data Source
14.3 Disclaimer
Table 1. Global Anti-Hypertensive Drugs Revenue by Type, (USD Million), 2021-2026
Table 2. Global Anti-Hypertensive Drugs Revenue by Application, (USD Million), 2021-2026
Table 3. Novartis Basic Information, Manufacturing Base and Competitors
Table 4. Novartis Major Business
Table 5. Novartis Anti-Hypertensive Drugs Product and Services
Table 6. Novartis Anti-Hypertensive Drugs Sales (K Units), Price (USD/Pcs), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 7. Pfizer Basic Information, Manufacturing Base and Competitors
Table 8. Pfizer Major Business
Table 9. Pfizer Anti-Hypertensive Drugs Product and Services
Table 10. Pfizer Anti-Hypertensive Drugs Sales (K Units), Price (USD/Pcs), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 11. Johnson & Johnson Basic Information, Manufacturing Base and Competitors
Table 12. Johnson & Johnson Major Business
Table 13. Johnson & Johnson Anti-Hypertensive Drugs Product and Services
Table 14. Johnson & Johnson Anti-Hypertensive Drugs Sales (K Units), Price (USD/Pcs), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 15. Sanofi Basic Information, Manufacturing Base and Competitors
Table 16. Sanofi Major Business
Table 17. Sanofi Anti-Hypertensive Drugs Product and Services
Table 18. Sanofi Anti-Hypertensive Drugs Sales (K Units), Price (USD/Pcs), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 19. Lupin Basic Information, Manufacturing Base and Competitors
Table 20. Lupin Major Business
Table 21. Lupin Anti-Hypertensive Drugs Product and Services
Table 22. Lupin Anti-Hypertensive Drugs Sales (K Units), Price (USD/Pcs), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 23. Ranbaxy Laboratories Basic Information, Manufacturing Base and Competitors
Table 24. Ranbaxy Laboratories Major Business
Table 25. Ranbaxy Laboratories Anti-Hypertensive Drugs Product and Services
Table 26. Ranbaxy Laboratories Anti-Hypertensive Drugs Sales (K Units), Price (USD/Pcs), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 27. Merck Basic Information, Manufacturing Base and Competitors
Table 28. Merck Major Business
Table 29. Merck Anti-Hypertensive Drugs Product and Services
Table 30. Merck Anti-Hypertensive Drugs Sales (K Units), Price (USD/Pcs), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 31. AstraZeneca Basic Information, Manufacturing Base and Competitors
Table 32. AstraZeneca Major Business
Table 33. AstraZeneca Anti-Hypertensive Drugs Product and Services
Table 34. AstraZeneca Anti-Hypertensive Drugs Sales (K Units), Price (USD/Pcs), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 35. Daiichi Sankyo Company Limited Basic Information, Manufacturing Base and Competitors
Table 36. Daiichi Sankyo Company Limited Major Business
Table 37. Daiichi Sankyo Company Limited Anti-Hypertensive Drugs Product and Services
Table 38. Daiichi Sankyo Company Limited Anti-Hypertensive Drugs Sales (K Units), Price (USD/Pcs), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 39. Takeda Pharmaceutical Basic Information, Manufacturing Base and Competitors
Table 40. Takeda Pharmaceutical Major Business
Table 41. Takeda Pharmaceutical Anti-Hypertensive Drugs Product and Services
Table 42. Takeda Pharmaceutical Anti-Hypertensive Drugs Sales (K Units), Price (USD/Pcs), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 43. Global Anti-Hypertensive Drugs Sales by Manufacturer (2019-2021e) & (K Units)
Table 44. Global Anti-Hypertensive Drugs Revenue by Manufacturer (2019-2021e) & (USD Million)
Table 45. Market Position of Manufacturers in Anti-Hypertensive Drugs, (Tier 1, Tier 2, and Tier 3), Based on Revenue in 2020
Table 46. Global Anti-Hypertensive Drugs Production Capacity by Company, (K Units): 2020 VS 2021
Table 47. Head Office and Anti-Hypertensive Drugs Production Site of Key Manufacturer
Table 48. Global Anti-Hypertensive Drugs Sales by Region (2016-2021e) & (K Units)
Table 49. Global Anti-Hypertensive Drugs Sales by Region (2021-2026) & (K Units)
Table 50. Global Anti-Hypertensive Drugs Revenue by Region (2016-2021e) & (USD Million)
Table 51. Global Anti-Hypertensive Drugs Revenue by Region (2021-2026) & (USD Million)
Table 52. Global Anti-Hypertensive Drugs Sales by Type (2016-2021e) & (K Units)
Table 53. Global Anti-Hypertensive Drugs Sales by Type (2021-2026) & (K Units)
Table 54. Global Anti-Hypertensive Drugs Revenue by Type (2016-2021e) & (USD Million)
Table 55. Global Anti-Hypertensive Drugs Revenue by Type (2021-2026) & (USD Million)
Table 56. Global Anti-Hypertensive Drugs Price by Type (2016-2021e) & (USD/Pcs)
Table 57. Global Anti-Hypertensive Drugs Price by Type (2021-2026) & (USD/Pcs)
Table 58. Global Anti-Hypertensive Drugs Sales by Application (2016-2021e) & (K Units)
Table 59. Global Anti-Hypertensive Drugs Sales by Application (2021-2026) & (K Units)
Table 60. Global Anti-Hypertensive Drugs Revenue by Application (2016-2021e) & (USD Million)
Table 61. Global Anti-Hypertensive Drugs Revenue by Application (2021-2026) & (USD Million)
Table 62. Global Anti-Hypertensive Drugs Price by Application (2016-2021e) & (USD/Pcs)
Table 63. Global Anti-Hypertensive Drugs Price by Application (2021-2026) & (USD/Pcs)
Table 64. North America Anti-Hypertensive Drugs Sales by Country (2016-2021e) & (K Units)
Table 65. North America Anti-Hypertensive Drugs Sales by Country (2021-2026) & (K Units)
Table 66. North America Anti-Hypertensive Drugs Revenue by Country (2016-2021e) & (USD Million)
Table 67. North America Anti-Hypertensive Drugs Revenue by Country (2021-2026) & (USD Million)
Table 68. North America Anti-Hypertensive Drugs Sales by Type (2016-2021e) & (K Units)
Table 69. North America Anti-Hypertensive Drugs Sales by Type (2021-2026) & (K Units)
Table 70. North America Anti-Hypertensive Drugs Sales by Application (2016-2021e) & (K Units)
Table 71. North America Anti-Hypertensive Drugs Sales by Application (2021-2026) & (K Units)
Table 72. Europe Anti-Hypertensive Drugs Sales by Country (2016-2021e) & (K Units)
Table 73. Europe Anti-Hypertensive Drugs Sales by Country (2021-2026) & (K Units)
Table 74. Europe Anti-Hypertensive Drugs Revenue by Country (2016-2021e) & (USD Million)
Table 75. Europe Anti-Hypertensive Drugs Revenue by Country (2021-2026) & (USD Million)
Table 76. Europe Anti-Hypertensive Drugs Sales by Type (2016-2021e) & (K Units)
Table 77. Europe Anti-Hypertensive Drugs Sales by Type (2021-2026) & (K Units)
Table 78. Europe Anti-Hypertensive Drugs Sales by Application (2016-2021e) & (K Units)
Table 79. Europe Anti-Hypertensive Drugs Sales by Application (2021-2026) & (K Units)
Table 80. Asia-Pacific Anti-Hypertensive Drugs Sales by Region (2016-2021e) & (K Units)
Table 81. Asia-Pacific Anti-Hypertensive Drugs Sales by Region (2021-2026) & (K Units)
Table 82. Asia-Pacific Anti-Hypertensive Drugs Revenue by Region (2016-2021e) & (USD Million)
Table 83. Asia-Pacific Anti-Hypertensive Drugs Revenue by Region (2021-2026) & (USD Million)
Table 84. Asia-Pacific Anti-Hypertensive Drugs Sales by Type (2016-2021e) & (K Units)
Table 85. Asia-Pacific Anti-Hypertensive Drugs Sales by Type (2021-2026) & (K Units)
Table 86. Asia-Pacific Anti-Hypertensive Drugs Sales by Application (2016-2021e) & (K Units)
Table 87. Asia-Pacific Anti-Hypertensive Drugs Sales by Application (2021-2026) & (K Units)
Table 88. South America Anti-Hypertensive Drugs Sales by Country (2016-2021e) & (K Units)
Table 89. South America Anti-Hypertensive Drugs Sales by Country (2021-2026) & (K Units)
Table 90. South America Anti-Hypertensive Drugs Revenue by Country (2016-2021e) & (USD Million)
Table 91. South America Anti-Hypertensive Drugs Revenue by Country (2021-2026) & (USD Million)
Table 92. South America Anti-Hypertensive Drugs Sales by Type (2016-2021e) & (K Units)
Table 93. South America Anti-Hypertensive Drugs Sales by Type (2021-2026) & (K Units)
Table 94. South America Anti-Hypertensive Drugs Sales by Application (2016-2021e) & (K Units)
Table 95. South America Anti-Hypertensive Drugs Sales by Application (2021-2026) & (K Units)
Table 96. Middle East & Africa Anti-Hypertensive Drugs Sales by Country (2016-2021e) & (K Units)
Table 97. Middle East & Africa Anti-Hypertensive Drugs Sales by Country (2021-2026) & (K Units)
Table 98. Middle East & Africa Anti-Hypertensive Drugs Revenue by Country (2016-2021e) & (USD Million)
Table 99. Middle East & Africa Anti-Hypertensive Drugs Revenue by Country (2021-2026) & (USD Million)
Table 100. Middle East & Africa Anti-Hypertensive Drugs Sales by Type (2016-2021e) & (K Units)
Table 101. Middle East & Africa Anti-Hypertensive Drugs Sales by Type (2021-2026) & (K Units)
Table 102. Middle East & Africa Anti-Hypertensive Drugs Sales by Application (2016-2021e) & (K Units)
Table 103. Middle East & Africa Anti-Hypertensive Drugs Sales by Application (2021-2026) & (K Units)
Table 104. Direct Channel Pros & Cons
Table 105. Indirect Channel Pros & Cons
Table 106. Anti-Hypertensive Drugs Typical Distributors
Table 107. Anti-Hypertensive Drugs Typical Customers
List of Figures
Figure 1. Anti-Hypertensive Drugs Picture
Figure 2. Global Anti-Hypertensive Drugs Sales Market Share by Type in 2020
Figure 3. Diuretics
Figure 4. Angiotensin Converting Enzyme (ACE) Inhibitors
Figure 5. Angiotensin Receptor Blockers (ARBs)
Figure 6. Calcium Channel Blockers
Figure 7. Beta Blockers
Figure 8. Alpha Blockers
Figure 9. Vasodilators
Figure 10. Renin Inhibitors
Figure 11. Global Anti-Hypertensive Drugs Sales Market Share by Application in 2020
Figure 12. Hospital Pharmacies
Figure 13. Retail Pharmacies
Figure 14. Online Pharmacies
Figure 15. Global Anti-Hypertensive Drugs Market Size, (USD Million) & (K Units): 2020 VS 2021 VS 2026
Figure 16. Global Anti-Hypertensive Drugs Market Size and Forecast (2016-2026) & (USD Million)
Figure 17. United States Anti-Hypertensive Drugs Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 18. Canada Anti-Hypertensive Drugs Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 19. Mexico Anti-Hypertensive Drugs Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 20. Germany Anti-Hypertensive Drugs Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 21. France Anti-Hypertensive Drugs Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 22. United Kingdom Anti-Hypertensive Drugs Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 23. Russia Anti-Hypertensive Drugs Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 24. Italy Anti-Hypertensive Drugs Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 25. China Anti-Hypertensive Drugs Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 26. Japan Anti-Hypertensive Drugs Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 27. Korea Anti-Hypertensive Drugs Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 28. India Anti-Hypertensive Drugs Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 29. Southeast Asia Anti-Hypertensive Drugs Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 30. Australia Anti-Hypertensive Drugs Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 31. Brazil Anti-Hypertensive Drugs Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 32. Egypt Anti-Hypertensive Drugs Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 33. Saudi Arabia Anti-Hypertensive Drugs Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 34. South Africa Anti-Hypertensive Drugs Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 35. Turkey Anti-Hypertensive Drugs Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 36. Global Anti-Hypertensive Drugs Sales (2016-2026) & (K Units)
Figure 37. Global Anti-Hypertensive Drugs Production Capacity (2016-2026) & (K Units)
Figure 38. Global Anti-Hypertensive Drugs Production Capacity by Geographic Region: 2020 VS 2021
Figure 39. Anti-Hypertensive Drugs Market Drivers
Figure 40. Anti-Hypertensive Drugs Market Restraints
Figure 41. Anti-Hypertensive Drugs Market Trends
Figure 42. Global Anti-Hypertensive Drugs Sales Market Share by Manufacturer in 2020
Figure 43. Global Anti-Hypertensive Drugs Revenue Market Share by Manufacturer in 2020
Figure 44. Anti-Hypertensive Drugs Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
Figure 45. Top 3 Anti-Hypertensive Drugs Manufacturer (Revenue) Market Share in 2020
Figure 46. Top 6 Anti-Hypertensive Drugs Manufacturer (Revenue) Market Share in 2020
Figure 47. Global Anti-Hypertensive Drugs Sales Market Share by Region (2016-2026)
Figure 48. Global Anti-Hypertensive Drugs Revenue Market Share by Region (2016-2026)
Figure 49. North America Anti-Hypertensive Drugs Revenue (2016-2026) & (USD Million)
Figure 50. Europe Anti-Hypertensive Drugs Revenue (2016-2026) & (USD Million)
Figure 51. Asia-Pacific Anti-Hypertensive Drugs Revenue (2016-2026) & (USD Million)
Figure 52. South America Anti-Hypertensive Drugs Revenue (2016-2026) & (USD Million)
Figure 53. Middle East & Africa Anti-Hypertensive Drugs Revenue (2016-2026) & (USD Million)
Figure 54. Global Anti-Hypertensive Drugs Sales Market Share by Type (2016-2026)
Figure 55. Global Anti-Hypertensive Drugs Revenue Market Share by Type (2016-2026)
Figure 56. Global Anti-Hypertensive Drugs Price by Type (2016-2026) & (USD/Pcs)
Figure 57. Global Anti-Hypertensive Drugs Sales Market Share by Application (2016-2026)
Figure 58. Global Anti-Hypertensive Drugs Revenue Market Share by Application (2016-2026)
Figure 59. Global Anti-Hypertensive Drugs Price by Application (2016-2026) & (USD/Pcs)
Figure 60. North America Anti-Hypertensive Drugs Sales Market Share by Country (2016-2026)
Figure 61. North America Anti-Hypertensive Drugs Revenue Market Share by Country (2016-2026)
Figure 62. North America Anti-Hypertensive Drugs Sales Market Share by Type (2016-2026)
Figure 63. North America Anti-Hypertensive Drugs Sales Market Share by Application (2016-2026)
Figure 64. Europe Anti-Hypertensive Drugs Sales Market Share by Country (2016-2026)
Figure 65. Europe Anti-Hypertensive Drugs Revenue Market Share by Country (2016-2026)
Figure 66. Europe Anti-Hypertensive Drugs Sales Market Share by Type (2016-2026)
Figure 67. Europe Anti-Hypertensive Drugs Sales Market Share by Application (2016-2026)
Figure 68. Asia-Pacific Anti-Hypertensive Drugs Sales Market Share by Region (2016-2026)
Figure 69. Asia-Pacific Anti-Hypertensive Drugs Revenue Market Share by Region (2016-2026)
Figure 70. Asia-Pacific Anti-Hypertensive Drugs Sales Market Share by Region (2016-2026)
Figure 71. Asia-Pacific Anti-Hypertensive Drugs Sales Market Share by Application (2016-2026)
Figure 72. South America Anti-Hypertensive Drugs Sales Market Share by Country (2016-2026)
Figure 73. South America Anti-Hypertensive Drugs Revenue Market Share by Country (2016-2026)
Figure 74. South America Anti-Hypertensive Drugs Sales Market Share by Type (2016-2026)
Figure 75. South America Anti-Hypertensive Drugs Sales Market Share by Application (2016-2026)
Figure 76. Middle East & Africa Anti-Hypertensive Drugs Sales Market Share by Country (2016-2026)
Figure 77. Middle East & Africa Anti-Hypertensive Drugs Revenue Market Share by Country (2016-2026)
Figure 78. Middle East & Africa Anti-Hypertensive Drugs Sales Market Share by Type (2016-2026)
Figure 79. Middle East & Africa Anti-Hypertensive Drugs Sales Market Share by Application (2016-2026)
Figure 80. Sales Channel: Direct Channel vs Indirect Channel
Figure 81. Methodology
Figure 82. Research Process and Data Source
高血圧薬の世界市場予測 2023年：メーカー別、地域別、種類・用途別 The standard definition of high blood pressure is determined by the Joint National Committee (JNC) on Detection, Evaluation, and Diagnosis of High Blood Pressure. A person is considered to have high blood pressure after three to six elevated blood pressure measurements over several months. These def…- アンジオテンシン受容体ブロッカーの世界市場2018-2025 Angiotensin II receptor blockers (ARBs), also known as angiotensin II receptor antagonists, AT1 receptor antagonists or sartans, are a group of pharmaceuticals that modulate the renin–angiotensin system. Their main uses are in the treatment of hypertension (high blood pressure), diabetic nephropathy…
- 高血圧薬の世界市場予測 2023年：メーカー別、地域別、種類・用途別 Hypertension or high blood pressure is the condition when blood pressure increases to the unhealthy level. Hypertension is very harmful and it can lead to stroke, heart failure, heart attack and kidney diseases. The main purpose of anti-hypertension drug is to lower and control high blood pressure t…
- 世界のアンジオテンシンII受容体拮抗薬市場 2021：企業別、地域別、種類・用途別 The Angiotensin II Receptor Blockers market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trad…
- 虚血性心疾患（IHD）薬の世界市場予測 2023年：メーカー別、地域別、種類・用途別 Ischemic heart disease (IHD), refers to a group of diseases which includes stable angina, unstable angina, myocardial infarction, and sudden cardiac death. It is within the group of cardiovascular diseases of which it is the most common type. A common symptom is chest pain or discomfort which may tr…